1. 1) Nishimoto N, Hashimoto J, Miyasaka N, et al. : Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an X ray reader-blinded randomized controlled trial of tocilizumab. Ann Rheum Dis 66: 1162-1167, 2007.
2. 2) Nishimoto N, Miyasaka N, Yamamoto K, et al. : Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis 68: 1580-1584, 2009.
3. 3) Hirao M, Hashimoto J, Tsuboi H, et al. : Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab. Ann Rheum Dis 68: 654-657, 2009.